Amgen Backs Therapeutic Antibody Firm
socalTECH
SEPTEMBER 8, 2011
Thousand Oaks-based biotech giant Amgen has backed a developer of therapeutic antibodies, via its venture capital arm, Amgen Ventures. Other investors in the round were ARCH Venture Partners, Canaan Partners, MPM Capital, Healthcare Ventures, Alexandria Real Estate Equities, and Zenyaku Kogyo. READ MORE>>.
Let's personalize your content